Brief: Novo's Wegovy Reduced Liver Fat To Normal Levels In 88.5% Of Obese Adults With Excess Liver Fat At Week 72

Novo Nordisk A/S

01/10/2026 11:45

Oct 1 (Reuters) - Novo Nordisk A/S NOVOb.CO:
NOVO NORDISK: WEGOVY REDUCED LIVER FAT TO NORMAL LEVELS IN 88.5% OF OBESE ADULTS WITH EXCESS LIVER FAT AT WEEK 72
NOVO NORDISK: ANALYSIS SHOWED EVEN PARTICIPANTS WITH LOW BASELINE LIVER FAT SAW IMPROVEMENTS IN LIVER HEALTH WITH WEGOVY TREATMENT
NOVO NORDISK: ANALYSIS SHOWED THAT 23 OF 26 PARTICIPANTS WITH LIVER FAT ABOVE 5% REACHED BELOW 5% THRESHOLD BY WEEK 72
NOVO NORDISK: MEASURES SHOWED LIVER FAT DECLINED FROM 8.8% TO 3.1% AT WEEK 72 WITH WEGOVY IN STEP UP TRIAL
Further company coverage: [NOVOb.CO]

 (Reporting by Zakia Mariyam)
 ((Zakia.Mariyam@thomsonreuters.com;))